In the past week, QTTB stock has gone up by 10.10%, with a monthly gain of 14.51% and a quarterly surge of 70.51%. The volatility ratio for the week is 8.00%, and the volatility levels for the last 30 days are 8.58% for Q32 Bio Inc. The simple moving average for the past 20 days is 15.19% for QTTB’s stock, with a 112.20% simple moving average for the past 200 days.
Is It Worth Investing in Q32 Bio Inc. (NASDAQ: QTTB) Right Now?
QTTB has 36-month beta value of -0.33. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 3 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for QTTB is 4.24M, and currently, short sellers hold a 7.38% ratio of that float. The average trading volume of QTTB on September 02, 2024 was 96.28K shares.
QTTB) stock’s latest price update
The stock of Q32 Bio Inc. (NASDAQ: QTTB) has increased by 10.81 when compared to last closing price of 39.24.Despite this, the company has seen a gain of 10.10% in its stock price over the last five trading days. prnewswire.com reported 2024-08-29 that WALTHAM, Mass., Aug. 29, 2024 /PRNewswire/ — Q32 Bio Inc. (Nasdaq: QTTB) (“Q32 Bio”), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced that management will participate in three upcoming investor conferences in September: Morgan Stanley 22nd Annual Global Healthcare Conference Date: Thursday, September 5, 2024 Location: New York, NY 2024 Cantor Fitzgerald Global Healthcare Conference Date: Tuesday, September 17, 2024 Presentation Time: 3:40 p.m.
Analysts’ Opinion of QTTB
Many brokerage firms have already submitted their reports for QTTB stocks, with Guggenheim repeating the rating for QTTB by listing it as a “Buy.” The predicted price for QTTB in the upcoming period, according to Guggenheim is $100 based on the research report published on June 17, 2024 of the current year 2024.
Leerink Partners, on the other hand, stated in their research note that they expect to see QTTB reach a price target of $54. The rating they have provided for QTTB stocks is “Outperform” according to the report published on May 21st, 2024.
Oppenheimer gave a rating of “Outperform” to QTTB, setting the target price at $50 in the report published on April 11th of the current year.
QTTB Trading at 44.21% from the 50-Day Moving Average
After a stumble in the market that brought QTTB to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 1.16% of gains for the given period.
Volatility was left at 8.58%, however, over the last 30 days, the volatility rate increased by 8.00%, as shares surge +14.81% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +171.24% upper at present.
During the last 5 trading sessions, QTTB rose by +10.10%, which changed the moving average for the period of 200-days by +134.52% in comparison to the 20-day moving average, which settled at $38.03. In addition, Q32 Bio Inc. saw 297.30% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at QTTB starting from TZIANABOS ARTHUR, who sale 265 shares at the price of $24.20 back on Mar 25 ’24. After this action, TZIANABOS ARTHUR now owns 7,983 shares of Q32 Bio Inc., valued at $6,413 using the latest closing price.
Alloway Paul, the of Q32 Bio Inc., sale 268 shares at $24.21 during a trade that took place back on Mar 25 ’24, which means that Alloway Paul is holding 2,596 shares at $6,488 based on the most recent closing price.
Stock Fundamentals for QTTB
Current profitability levels for the company are sitting at:
- -35.79 for the present operating margin
- 0.8 for the gross margin
The net margin for Q32 Bio Inc. stands at -34.98. The total capital return value is set at -0.62. Equity return is now at value -85.06, with -44.30 for asset returns.
Based on Q32 Bio Inc. (QTTB), the company’s capital structure generated 0.29 points at debt to capital in total, while cash flow to debt ratio is standing at -5.99. The debt to equity ratio resting at 0.41. The interest coverage ratio of the stock is -39.14.
Currently, EBITDA for the company is -91.52 million with net debt to EBITDA at 0.95. When we switch over and look at the enterprise to sales, we see a ratio of 240.21. The receivables turnover for the company is 3.3for trailing twelve months and the total asset turnover is 0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.49.
Conclusion
To put it simply, Q32 Bio Inc. (QTTB) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
